HUMAW

Conviction 20Scan · Fri, Jun 26, 2026

HUMAW$0.0106+76.67%

ResistanceSupportVol 14

Vol MA14 112.65K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Humacyte, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.humacyte.com ↗

Price0.0106

Change+76.67%

Gap+33.33%

Rel volume48.50×

Avg volume82.36K

Avg $ vol1.1K

SMA 200.0293

SMA 500.0573

SMA 2000.1268

Price vs 50-81.49%

Price vs 200-91.64%

MA stackbearish

50/200 cross—

Supertrenddown · 0.0492

RSI (14)42

MACD hist-0.00

MACD cross—

Stoch %K / %D15 / 9

ADX (14)11

+DI / −DI28 / 35

RSI divergence—

MACD divergence—

ATR %+153.87%

ADR %47.39%

52w high0.5900

52w low0.0000

From 52w high-98.20%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width309.21%

%B0.29

Donchian pos14.15%

Donchian high0.0749

Donchian low0.0000

AVWAP (52w high)0.1220

vs AVWAP high-91.31%

AVWAP (52w low)0.1213

vs AVWAP low-91.26%

OBV trendUp

Chaikin MF (20)-0.04

Today vs 20d48.50×

Avg vol (14d)112.65K

Avg vol (20d)82.36K

Avg $ vol (20d)1.1K

Market cap—

RS 3m (vs SPY)-105.39%

RS 6m (vs SPY)-101.74%

RS line new highNo

Trend template0/8

Technical rank6.3

1 week+51.43%

1 month-81.31%

3 months-88.05%

6 months-89.40%

1 year-97.54%

YTD-89.36%

P/E-0.03

P/B0.11

P/S0.64

P/FCF-0.01

EPS-0.2600

Div yield—

ROE-351.28%

ROA-36.93%

Debt/Eq3.09

Current3.93

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth72.54%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-11.36M

Revenue495K

Net income-17.62M

Gross profit—

Free cash flow-105.93M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees184

ListedFri, Aug 27, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank6.3 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.1020

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HUMAW

All disclosures →

No recent disclosed trades by Congress in HUMAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HUMAW

No recent insider (Form 4) filings in HUMAW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in HUMAW

EDGAR →

No recent SEC filings on file for HUMAW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.